Followers | 23 |
Posts | 2036 |
Boards Moderated | 0 |
Alias Born | 12/06/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 08, 2021 1:01:16 PM
Recent ADTX News
- Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024 • Business Wire • 08/29/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:30:21 PM
- Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) • Business Wire • 08/26/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:44:14 PM
- Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics • Business Wire • 08/21/2024 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:16:12 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:15:25 PM
- Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 • PR Newswire (US) • 08/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:15:09 PM
- Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic Plans • Business Wire • 08/13/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:15:21 PM
- Aditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • Business Wire • 08/09/2024 08:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 02:28:09 PM
- Aditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • Business Wire • 08/09/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 01:44:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:03:52 AM
- Biotech Soars Despite Broader Selloff • AllPennyStocks.com • 08/07/2024 07:25:00 PM
- Aditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian Cancer • Business Wire • 08/07/2024 12:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/07/2024 04:15:16 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/01/2024 08:15:15 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/01/2024 08:15:13 PM
- Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st • GlobeNewswire Inc. • 07/25/2024 01:00:00 PM
- Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition • Business Wire • 07/25/2024 12:30:00 PM
- Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 • PR Newswire (US) • 07/23/2024 12:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 08:15:08 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM